Volume 27, Number 5—May 2021
Research
Susceptibility to SARS-CoV-2 of Cell Lines and Substrates Commonly Used to Diagnose and Isolate Influenza and Other Viruses
Table 2
Assay identification | Applicable cell lines | Primers/probes* | Sequence, 5′ → 3′ |
---|---|---|---|
ACE2.FAM.10 |
Vero E6, A549, CRFK, CV-1 |
Forward | CCCAGAATCCTTGAGTCAT |
Probe | TACTGATGCAATGGTGAACC | ||
Reverse |
TTGGACAGAAACCAAACATAG |
||
ACE2.FAM.11 |
Vero E6, CRFK |
Forward | GGGTCACAGTATGTTTCATC |
Probe | TATCTCTCGCTTCATCTCCC | ||
Reverse |
GGAGGTGGATGGTCTTTA |
||
ACE2.FAM.12 |
Vero E6, MDCK-NBL-2, MDCK-SIAT1 |
Forward | TGGTCTTTGGGAATTTCA |
Probe | TAAAGACCATCCACCTCCAC | ||
Reverse |
GAAATCATGTCACTTTCTGC |
||
ACE2.FAM.13 |
Vero E6, MDCK-NBL-2, MDCK-SIAT1 |
Forward | AACATGGAACAGAGATGC |
Probe | CCAAAGACCAGTGGATGAAA | ||
Reverse |
GGAGGTGGATGGTCTTTA |
||
ACE2.FAM.14 |
Vero E6, Mv1Lu |
Forward | CTTCATAGTCTCCTCTCCAATAA |
Probe | CTCTTCATATAATGGCCTCAGC | ||
Reverse |
CTACAATGAGAGGCTCTGG |
||
ACE2.FAM.15 |
Vero E6, Mv1Lu |
Forward | CTCTTCATATAATGGCCTCAG |
Probe | AGACTACAATGAGAGGCTCT | ||
Reverse |
ATGAGCACCATCTACAGT |
||
ACE2.FAM.16 | Vero E6, A549, CV-1 | Forward | GGGTCACAGTATGTTTCATC |
Probe | TATCTCTCGCTTCATCTCCC | ||
Reverse | GGAGGTGGATGGTCTTTA |
*Probes labeled at the 5′-end with the reporter molecule 6-carboxyfluorescein (FAM), internally with the quencher ZEN, and at the 3′-end with Iowa Black FQ (Integrated DNA Technologies, https://www.idtdna.com).
Page created: February 24, 2021
Page updated: April 20, 2021
Page reviewed: April 20, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.